Xenon Pharmaceuticals (XENE) Amortizatization of Intangibles (2018 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $334000.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 4.7% to $334000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 4.7% year-over-year, with the annual reading at $1.3 million for FY2025, 4.7% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $334000.0 at Xenon Pharmaceuticals, up from $330000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $334000.0 in Q4 2025, with the low at -$4.6 million in Q4 2023.
  • Average Amortizatization of Intangibles over 3 years is -$229888.9, with a median of $319000.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles surged 106.88% in 2024, then rose 4.21% in 2025.
  • Over 3 years, Amortizatization of Intangibles stood at -$4.6 million in 2023, then soared by 106.88% to $319000.0 in 2024, then rose by 4.7% to $334000.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $334000.0, $330000.0, and $327000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.